Moleculin Biotech Inc

NASDAQ:MBRX   3:59:41 PM EDT
3.53
+0.20 (+6.01%)
Products

Moleculin Announces Annamycin Receives FDA Orphan Drug Designation For Soft Tissue Sarcomas

Published: 12/29/2020 13:05 GMT
Moleculin Biotech Inc (MBRX) - Moleculin Announces Annamycin Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas.